Medical and Pharmaceutical Long overdue lung cancer screening program coming to PEI, health minister says It will get phased in within the next 2 years Rowan DunneApril 8, 2025
Medical and Pharmaceutical Former nuclear test site workers advised to get screened for lung cancer The Worker Health Protection Program's screening initiative has helped catch cases linked to radiation exposure in their early stages Rowan DunneApril 7, 2025
Medical and Pharmaceutical Median Technologies clears hurdle on the way to regulatory acceptance in EU and US The company has met a key requirement for regulatory submissions in the US and Europe Joseph MortonApril 3, 2025
AI and Autonomy Ohio hospital wants to know if AI is better at lung cancer detection than radiologists Artificial intelligence has proven its ability to detect the disease years before symptoms manifest Rowan DunneApril 2, 2025
Medical and Pharmaceutical More X-ray referrals = more lung cancer survivors, study finds The disease can often be eliminated through surgery or targeted radiation in its early stages Rowan DunneMarch 31, 2025
Medical and Pharmaceutical South Korean research institution develops lung cancer breath test with 95% accuracy It uses a machine with 70 sensors to detect volatile organic compounds associated with the disease Rowan DunneMarch 25, 2025
Health and Safety Five startups taking aim at cancer diagnosis and treatment Statistics Canada reports that lung cancer was the leading cause for both men and women Joseph MortonMarch 21, 2025
Medical and Pharmaceutical Chicago woman’s shock lung cancer diagnosis inspires her to spread awareness Thankfully, early detection and treatment measures are bringing hope to people who receive the unfortunate news Rowan DunneMarch 13, 2025
Medical and Pharmaceutical Indiana’s ‘Fight for Air Climb’ raises over US$210K to combat lung diseases More than 480 residents participated in the American Lung Association's annual event Rowan DunneMarch 10, 2025
Medical and Pharmaceutical Checkpoint Therapeutics gets picked up by Sun Pharma, enjoys 60% share bump The deal could provide shareholders with an extra $0.70 per share if company's drug gains regulatory approval in Europe Joseph MortonMarch 10, 2025